Doxorubicin- and daunorubicin-glutathione conjugates, but not unconjugated drugs, competitively inhibit leukotriene C4 transport mediated by MRP/GS-X pump

Biochemical and Biophysical Research Communications
W PriebeT Ishikawa

Abstract

Overexpression of the multidrug resistance-associated protein (MRP1) gene encoding a human GS-X pump in cultured cells resulted in increased cellular resistance to antitumor agents, including doxorubicin (Dox) and daunomycin (Dau), as well as certain heavy metals. However, studies with membrane vesicles prepared from the resistant cells revealed that Dox and Dau are poor substrates for the transport mediated by MRP/GS-X pump, suggesting that metabolic modifications of these drugs might be required for the transport. To test this hypothesis, we prepared four glutathione conjugates by linking the cysteine residue of GSH to Dox and Dau at eitehr the C-7 or C-14 position. The affinity of the synthesized conjugates toward MRP/GS-X pump was examined in the LTC4 transport assay using membrane vesicles prepared from an MRP1 gene-overexpressing cell line, SR3A. Unconjugated Dox and Dau failed to inhibit the transport of LTC4, whereas 30 microM GS-Dox or GS-Dau conjugates completely inhibited the transport. Kinetic analyses revealed that the inhibition by these GS-conjugates is competitive with Ki values ranging from 60 to 200 nM, suggesting that these compounds have high affinities toward MRP/GS-X pump and share the common binding site(...Continue Reading

References

Aug 1, 1979·Journal of Medicinal Chemistry·E M ActonD W Henry
Nov 1, 1995·Journal of the National Cancer Institute·T IshikawaM Suzuki
Aug 15, 1995·Proceedings of the National Academy of Sciences of the United States of America·G J ZamanP Borst
Dec 20, 1994·Proceedings of the National Academy of Sciences of the United States of America·M MüllerP L Jansen
Sep 13, 1994·Proceedings of the National Academy of Sciences of the United States of America·G J ZamanH J Broxterman
Mar 1, 1994·European Journal of Biochemistry·I LeierD Keppler
Jun 25, 1996·Proceedings of the National Academy of Sciences of the United States of America·R TommasiniE Martinoia

❮ Previous
Next ❯

Citations

May 3, 2006·Biological & Pharmaceutical Bulletin·Masuhiro NishimuraAiko Yamauchi
Dec 20, 2003·Pharmacogenomics·Toshihisa IshikawaYasuhiro Sumino
Jul 10, 1999·International Journal of Cancer. Journal International Du Cancer·T IidaT Kondo
Mar 10, 2000·FEBS Letters·J H HooijbergH J Broxterman
Sep 24, 2004·International Journal of Cancer. Journal International Du Cancer·Rajendra SharmaSanjay Awasthi
Nov 28, 2002·International Journal of Cancer. Journal International Du Cancer·Robert L ShepardAnne H Dantzig
Oct 3, 2002·Japanese Journal of Cancer Research : Gann·Shinji GotoTakahito Kondo
Jan 17, 2020·Critical Reviews in Toxicology·Patrick E Hanna, M W Anders
Dec 1, 2001·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·S GotoT Kondo
Aug 5, 2000·American Journal of Physiology. Renal Physiology·R A Van AubelF G Russel
May 15, 2001·International Journal of Cancer. Journal International Du Cancer·A HarbottleF C Campbell
Apr 23, 2019·Cancer Cell International·Eric Chekwube AniogoHeidi Abrahamse
Jul 9, 2009·Chemical Reviews·Paul D W Eckford, Frances J Sharom
Feb 6, 2009·Journal of Medicinal Chemistry·Janaina Fernandes, Cerli R Gattass
Dec 3, 1999·Biochimica Et Biophysica Acta·D R HipfnerS P Cole
Sep 1, 2001·Environmental Toxicology and Pharmacology·N H CnubbenP J van Bladeren
Sep 3, 2002·Advanced Drug Delivery Reviews·Alexander V KabanovValery Yu Alakhov
Jan 18, 2003·Journal of Pharmaceutical Sciences·Hang NguyenMarilyn E Morris
Dec 4, 2003·Biochimica Et Biophysica Acta·Tomomi Sugiyama, Yasuyuki Sadzuka
Sep 8, 2009·International Journal of Pharmaceutics·Yasuyuki SadzukaTakashi Sonobe

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.